Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry | Zendy

David L. Horn | Zendy; Dionysios Neofytos | Zendy; Elias Anaissie | Zendy; Jay A. Fishman | Zendy; William J. Steinbach | Zendy; Ali J. Olyaei | Zendy; Kieren A. Marr | Zendy; Michael A. Pfaller | Zendy; ChiHsing Chang | Zendy; Karen M. Webster | Zendy

Open Access

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

Author(s) -

David L. Horn,

Dionysios Neofytos,

Elias Anaissie,

Jay A. Fishman,

William J. Steinbach,

Ali J. Olyaei,

Kieren A. Marr,

Michael A. Pfaller,

ChiHsing Chang,

Karen M. Webster

Publication year - 2009

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/599039

Subject(s) - medicine , fluconazole , candida krusei , candida parapsilosis , epidemiology , incidence (geometry) , mortality rate , neutropenia , candida albicans , antifungal , chemotherapy , microbiology and biotechnology , biology , dermatology , physics , optics

Candidemia remains a major cause of morbidity and mortality in the health care setting, and the epidemiology of Candida infection is changing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research